{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:38:31Z","timestamp":1790217511921,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People with rare disorders face significant global health inequalities; the challenge is how to raise awareness and develop a nucleus of experts in a country who are then able to provide guidance to others in that country. The International Prader\u2013Willi Syndrome Organisation (IPWSO) established Project ECHO<jats:sup>\u00ae<\/jats:sup> with the aim of facilitating the sharing of knowledge and the building of international partnerships to reduce global health inequalities for a particular rare genetically-determined neurodevelopmental disorder, Prader\u2013Willi Syndrome (PWS). Four different ECHO programmes were established for the following groups: (a) Individuals (usually parents) who had taken on a leadership role in their country; (b) health professionals interested in PWS; (c) professional care providers supporting children and adults with PWS; and (d) a Latin American ECHO in Spanish. The programme started in 2020 and an evaluation was undertaken after one year to determine: the extent to which IPWSO had been able to recruit and retain individuals globally; the nature and extent of any benefits gained from the sessions; and examples of how individual involvement in the programme had led to local benefits. The methods included analysing routinely kept process indicators and survey data from the attendees of one component of the programme (the Leadership ECHO), together with a qualitative analysis of survey data and recorded interviews of attendees from countries of differing socio-economic status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe the IPWSO ECHO programme and report on the outcomes from the evaluation of one aspect of the programme, the Leadership ECHO. Attendance of the Leadership ECHO sessions was satisfactory, with a mean of 24.7 participants, with participants attending a mean of 5.67 sessions, i.e., 30% of sessions. There was also good global reach, with individuals attending from 34 countries, although there were notable geographic regions with very limited representation. Feedback and interviews demonstrated the positive impact of the programme with some early evidence of positive developments at national level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Families and professionals from countries with a range of expertise and services offered to people with PWS remained engaged throughout the ECHO programme, established networks of support and fostered the development of good practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02504-5","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T13:02:38Z","timestamp":1666357358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reducing global health inequalities for a rare disorder: evaluating the international Prader\u2013Willi Syndrome Organisation\u2019s Echo\u00ae programme"],"prefix":"10.1186","volume":"17","author":[{"given":"Tanzil","family":"Rujeedawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"McNairney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Cordner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Loughnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4107-130X","authenticated-orcid":false,"given":"Anthony","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"2504_CR1","unstructured":"EURORDIS. The voice of 12000 patients: experiences and expectations of rare disease patients on diagnosis and care in Europe. Published online 2009:325. https:\/\/www.eurordis.org\/IMG\/pdf\/voice_12000_patients\/EURORDISCARE_FULLBOOKr.pdf."},{"issue":"1","key":"2504_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23937\/2643-4571\/1710008","volume":"2","author":"R Agrawal","year":"2019","unstructured":"Agrawal R, Amaresh Rao M, Brian M, et al. Baseline knowledge of rare diseases in India\u2014a survey. Int J Rare Dis Disord. 2019;2(1):4\u201311. https:\/\/doi.org\/10.23937\/2643-4571\/1710008.","journal-title":"Int J Rare Dis Disord"},{"issue":"10","key":"2504_CR3","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/ACM.0000000000001328","volume":"91","author":"C Zhou","year":"2016","unstructured":"Zhou C, Crawford A, Serhal E, Kurdyak P, Sockalingam S. The impact of project ECHO on participant and patient outcomes: a systematic review. Acad Med. 2016;91(10):1439\u201361. https:\/\/doi.org\/10.1097\/ACM.0000000000001328.","journal-title":"Acad Med"},{"key":"2504_CR4","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","volume":"364","author":"S Arora","year":"2011","unstructured":"Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. New Engl J Med. 2011;364:2199\u2013207.","journal-title":"New Engl J Med"},{"issue":"1","key":"2504_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10\u201326. https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0.","journal-title":"Genet Med."},{"key":"2504_CR6","unstructured":"Economist TEIU. Navigating rare neurological diseases: meeting the challenge for policy makers, patients and healthcare professionals."},{"issue":"1","key":"2504_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41588-019-0552-2","volume":"52","author":"GS Baynam","year":"2020","unstructured":"Baynam GS, Groft S, van der Westhuizen FH, et al. A call for global action for rare diseases in Africa. Nat Genet. 2020;52(1):21\u20136. https:\/\/doi.org\/10.1038\/s41588-019-0552-2.","journal-title":"Nat Genet"},{"issue":"1","key":"2504_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cts.12501","volume":"11","author":"HJS Dawkins","year":"2018","unstructured":"Dawkins HJS, Draghia-Akli R, Lasko P, et al. Progress in rare diseases research 2010\u20132016: an IRDiRC perspective. Clin Transl Sci. 2018;11(1):11\u201320. https:\/\/doi.org\/10.1111\/cts.12501.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"2504_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cts.12500","volume":"11","author":"CP Austin","year":"2018","unstructured":"Austin CP, Cutillo CM, Lau LPL, et al. Future of rare diseases research 2017\u20132027: an IRDiRC perspective. Clin Transl Sci. 2018;11(1):21\u20137. https:\/\/doi.org\/10.1111\/cts.12500.","journal-title":"Clin Transl Sci"},{"key":"2504_CR10","doi-asserted-by":"publisher","DOI":"10.23937\/2643-4571\/1710036","author":"A Holland","year":"2021","unstructured":"Holland A, Hughes M. Reducing global health inequalities in people with Prader\u2013Willi syndrome: the role of the international Prader\u2013Willi syndrome organization. Int J Rare Dis Disord. 2021. https:\/\/doi.org\/10.23937\/2643-4571\/1710036.","journal-title":"Int J Rare Dis Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02504-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T13:13:39Z","timestamp":1666358019000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02504-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02504-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University of Cambridge Psychology Ethics Committee gave ethical approval for the evaluation (reference PRE.2021.060).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants in the ECHO programme agreed that data on attendance and information from regular surveys could be collected and submitted for publication on the understanding that individuals and particular countries would not be identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NM and SC are employees of IPWSO, AH, JO\u2019B and GL are or have been Trustees of IPWSO.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}